Proteomics analysis of cardiac extracellular matrix remodeling in a porcine model of ischemia/reperfusion injury

Circulation

Volumn 125, Issue 6, 2012, Pages 789-802

  Barallobre Barreiro, Javier ^a   Didangelos, Athanasios ^c   Schoendube, Friedrich A ^e   Drozdov, Ignat ^c,d   Yin, Xiaoke ^c   Fernández Caggiano, Mariana ^a   Willeit, Peter ^f   Puntmann, Valentina O ^c   Aldama López, Guillermo ^b   Shah, Ajay M ^c   Doménech, Nieves ^a   Mayr, Manuel ^c  

^a Research Unit/INIBIC CHUAC   (Spain)

^b CHUAC Interventional Cardiology Unit   (Spain)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY OF GÖTTINGEN   (Germany)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Extracellular matrix; Fibrosis; Myocardial ischemia; Proteomics; Ventricular remodeling

Indexed keywords

ASPORIN; CARTILAGE INTERMEDIATE LAYER PROTEIN 1; COLLAGEN; COLLAGEN ALPHA1 CHAIN; EXTRACELLULAR ADIPOCYTE ENHANCER BINDING PROTEIN 1; LEUCINE; MATRILIN 4; MEMBRANE PROTEIN; MESSENGER RNA; PROLARGIN; PROTEOGLYCAN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GENE EXPRESSION; HEART INFARCTION; HEART INJURY; HEART MUSCLE ISCHEMIA; HEART VENTRICLE REMODELING; HUMAN; HUMAN TISSUE; ISCHEMIC CARDIOMYOPATHY; LIQUID CHROMATOGRAPHY; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEOMICS; REPERFUSION INJURY; SIGNAL TRANSDUCTION; SWINE; TANDEM MASS SPECTROMETRY; VALIDATION PROCESS;

ANIMALS; BIOLOGICAL MARKERS; CHROMATOGRAPHY, LIQUID; DRUG DISCOVERY; EXTRACELLULAR MATRIX PROTEINS; FIBROSIS; GENE EXPRESSION PROFILING; HEART TRANSPLANTATION; HUMANS; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; PROGNOSIS; PROTEOMICS; RANDOM ALLOCATION; RNA, MESSENGER; SUS SCROFA; SWINE; TANDEM MASS SPECTROMETRY; TRANSFORMING GROWTH FACTOR BETA1; VENTRICULAR REMODELING;

EID: 84857615660     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.111.056952     Document Type: Article

References (36)

1. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction: experimental observations and clinical implications. Circulation. 1990; 81: 1161-1172. (Pubitemid 20119612)
2. van den Borne SW, Diez J, Blankesteijn WM, Verjans J, Hofstra L, Narula J. Myocardial remodeling after infarction: the role of myofibroblasts. Nat Rev Cardiol. 2010; 7: 30-37.
3. Volders PG, Willems IE, Cleutjens JP, Arends JW, Havenith MG, Daemen MJ. Interstitial collagen is increased in the non-infarcted human myocardium after myocardial infarction. J Mol Cell Cardiol. 1993; 25: 1317-1323. (Pubitemid 24003838)
4. Sutton MG, Sharpe N. Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation. 2000; 101: 2981-2988. (Pubitemid 30415891)
5. Baudino TA, Carver W, Giles W, Borg TK. Cardiac fibroblasts: friend or foe? Am J Physiol Heart Circ Physiol. 2006; 291: H1015-H1026. (Pubitemid 44343642)
6. Cleutjens JP, Blankesteijn WM, Daemen MJ, Smits JF. The infracted myocardium: simply dead tissue, or a lively target for therapeutic interventions. Cardiovasc Res. 1999; 44: 232-241. (Pubitemid 29474084)
7. Berk BC, Fujiwara K, Lehoux S. ECM remodeling in hypertensive heart disease. J Clin Invest. 2007; 117: 568-575. (Pubitemid 46348511)
8. van den Borne SW, Isobe S, Zandbergen HR, Li P, Petrov A, Wong ND, Fujimoto S, Fujimoto A, Lovhaug D, Smits JF, Daemen MJ, Blankesteijn WM, Reutelingsperger C, Zannad F, Narula N, Vannan MA, Pitt B, Hofstra L, Narula J. Molecular imaging for efficacy of pharmacologic intervention in myocardial remodeling. J Am Coll Cardiol Cardiovasc Imaging. 2009; 2: 187-198.
9. Cieniewski-Bernard C, Mulder P, Henry JP, Drobecq H, Dubois E, Pottiez G, Thuillez C, Amouyel P, Richard V, Pinet F. Proteomic analysis of left ventricular remodeling in an experimental model of heart failure. J Proteome Res. 2008; 7: 5004-5016.
10. Mayr M, Yusuf S, Weir G, Chung YL, Mayr U, Yin X, Ladroue C, Madhu B, Roberts N, De Souza A, Fredericks S, Stubbs M, Griffiths JR, Jahangiri M, Xu Q, Camm AJ. Combined metabolomic and proteomic analysis of human atrial fibrillation. J Am Coll Cardiol. 2008; 51: 585-594.
11. Arrell DK, Neverova I, Van Eyk JE. Cardiovascular proteomics: evolution and potential. Circ Res. 2001; 88: 763-773.
12. Yin X, Cuello F, Mayr U, Hao Z, Hornshaw M, Ehler E, Avkiran M, Mayr M. Proteomics analysis of the cardiac myofilament subproteome reveals dynamic alterations in phosphatase subunit distribution. Mol Cell Proteomics. 2010; 9: 497-509.
13. Mayr M, Liem D, Zhang J, Li X, Avliyakulov NK, Yang JI, Young G, Vondriska TM, Ladroue C, Madhu B, Griffiths JR, Gomes A, Xu Q, Ping P. Proteomic and metabolomic analysis of cardioprotection: Interplay between protein kinase C epsilon and delta in regulating glucose metabolism of murine hearts. J Mol Cell Cardiol. 2009; 46: 268-277.
14. Gramolini AO, Kislinger T, Alikhani-Koopaei R, Fong V, Thompson NJ, Isserlin R, Sharma P, Oudit GY, Trivieri MG, Fagan A, Kannan A, Higgins DG, Huedig H, Hess G, Arab S, Seidman JG, Seidman CE, Frey B, Perry M, Backx PH, Liu PP, MacLennan DH, Emili A. Comparative proteomics profiling of a phospholamban mutant mouse model of dilated cardiomyopathy reveals progressive intracellular stress responses. Mol Cell Proteomics. 2008; 7: 519-533. (Pubitemid 351472462)
15. Franklin S, Zhang MJ, Chen H, Paulsson AK, Mitchell-Jordan SA, Li Y, Ping P, Vondriska TM. Specialized compartments of cardiac nuclei exhibit distinct proteomic anatomy. Mol Cell Proteomics. 2011; 10: M110.000703.
16. Didangelos A, Yin X, Mandal K, Baumert M, Jahangiri M, Mayr M. Proteomic characterization of extracellular space components in the human aorta. Mol Cell Proteomics. 2010; 9: 2048-2062.
17. Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci U S A. 2003; 100: 9440-9445. (Pubitemid 37033947)
18. Cheadle C, Vawter MP, Freed WJ, Becker KG. Analysis of microarray data using Z score transformation. J Mol Diagn. 2003; 5: 73-81. (Pubitemid 36553428)
19. Schellings MW, van Almen GC, Sage EH, Heymans S. Thrombospondins in the heart: potential functions in cardiac remodeling. J Cell Commun Signal. 2009; 3: 201-213.
20. Snider P, Hinton RB, Moreno-Rodriguez RA, Wang J, Rogers R, Lindsley A, Li F, Ingram DA, Menick D, Field L, Firulli AB, Molkentin JD, Markwald R, Conway SJ. Periostin is required for maturation and extracellular matrix stabilization of noncardiomyocyte lineages of the heart. Circ Res. 2008; 102: 752-760. (Pubitemid 351521582)
21. Ott HC, Matthiesen TS, Goh SK, Black LD, Kren SM, Netoff TI, Taylor DA. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat Med. 2008; 14: 213-221. (Pubitemid 351214548)
22. McCurdy S, Baicu CF, Heymans S, Bradshaw AD. Cardiac extracellular matrix remodeling: fibrillar collagens and secreted protein acidic and rich in cysteine (SPARC). J Mol Cell Cardiol. 2010; 48: 544-549.
23. Dobaczewski M, Gonzalez-Quesada C, Frangogiannis NG. The extracellular matrix as a modulator of the inflammatory and reparative response following myocardial infarction. J Mol Cell Cardiol. 2010; 48: 504-511.
24. Kohl P, Camelliti P, Burton FL, Smith GL. Electrical coupling of fibroblasts and myocytes: relevance for cardiac propagation. J Electrocardiol. 2005; 38: 45-50. (Pubitemid 41436486)
25. 2, and PDGF, partners in fibroblast activation. Circ Res. 2010; 106: 1675-1680.
26. Hynes RO. The extracellular matrix: not just pretty fibrils. Science. 2009; 326: 1216-1219.
27. Lorenzo P, Neame P, Sommarin Y, Heinegârd D. Cloning and deduced amino acid sequence of a novel cartilage protein (CILP) identifies a proform including a nucleotide pyrophosphohydrolase. J Biol Chem. 1998; 273: 23469-23475. (Pubitemid 28417538)
28. Johnson K, Farley D, Hu SI, Terkeltaub R. One of two chondrocyteexpressed isoforms of cartilage intermediate-layer protein functions as an insulin-like growth factor 1 antagonist. Arthritis Rheum. 2003; 48: 1302-1314. (Pubitemid 36554529)
29. Yao Z, Nakamura H, Masuko-Hongo K, Suzuki-Kurokawa M, Nishioka K, Kato T. Characterisation of cartilage intermediate layer protein (CILP)-induced arthropathy in mice. Ann Rheum Dis. 2004; 63: 252-258. (Pubitemid 38250666)
30. Seki S, Kawaguchi Y, Chiba K, Mikami Y, Kizawa H, Oya T, Mio F, Mori M, Miyamoto Y, Masuda I, Tsunoda T, Kamata M, Kubo T, Toyama Y, Kimura T, Nakamura Y, Ikegawa S. A functional SNP in CILP, encoding cartilage intermediate layer protein, is associated with susceptibility to lumbar disc disease. Nat Genet. 2005; 37: 607-612. (Pubitemid 40770415)
31. Kou I, Nakajima M, Ikegawa S. Binding characteristics of the osteoarthritis-associated protein asporin. J Bone Miner Metab. 2010; 28: 395-402.
32. Nakajima M, Kizawa H, Saitoh M, Kou I, Miyazono K, Ikegawa S. Mechanisms for asporin function and regulation in articular cartilage. J Biol Chem. 2007; 282: 32185-32192. (Pubitemid 350106455)
33. Okamoto O, Fujiwara S. Dermatopontin, a novel player in the biology of the extracellular matrix. Connect Tissue Res. 2006; 47: 177-189. (Pubitemid 44463524)
34. Langham RG, Egan MK, Dowling JP, Gilbert RE, Thomson NM. Transforming growth factor-beta1 and tumor growth factor-beta-inducible gene-H3 in nonrenal transplant cyclosporine nephropathy. Transplantation. 2001; 72: 1826-1829. (Pubitemid 33144239)
35. Thapa N, Kang KB, Kim IS. Beta ig-h3 mediates osteoblast adhesion and inhibits differentiation. Bone. 2005; 36: 232-242. (Pubitemid 40283580)
36. Zanin MK, Bundy J, Ernst H, Wessels A, Conway SJ, Hoffman S. Distinct spatial and temporal distributions of aggrecan and versican in the embryonic chick heart. Anat Rec. 1999; 256: 366-380.